Replies to post #420357 on Amarin Corp Plc (AMRN)

[Jasbg]

DCM8, Thanks for a great article and 'follow up' - on Holts recent presentation on JP.

Here from the article:

Bottom line

AMRN is a buy at these prices - once again. My assessment is based on

a) Sarissa’s all-out endeavour to turn Amarin around,

b) Sarissa’s buying Amarin shares and not selling shares, putting money where their mouth is,

c) implementing some of the proposed strategies over which 80% shareholders voted for them,*

d) the new CEO’s previous expertise in the cardiovascular “turnaround” space,

e) Sarissa’s previous expertise in the same space with The Medicines Company, and f) the new earnings figures, which supports points a to e.

[ziploc_1]

Interesting article on Amarin's future...However, probably in the interest of brevity, the author did not mention...potential new EPA products which, are catalysts for Amarin, such as EPAMAX(patent applied for) which is a new formulation of EPA, allowing it to be better carried in the lymphatic system(and better cross the blood- brain barrier) for the treatment of ...

-cardiopulmonary,,cardiovascular, and cerebrovascular diseases(including Alzheimers)
-cancers(including lymphoma)

-huge potential in China